Back to Trades
Im Ellie Eunkyung
Chief Medical OfficerCIK 0002075219
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2025–2026
Im Ellie Eunkyung, Chief Medical Officer, has filed 3 SEC reports (2025–2026), all concentrated in CRESCENT BIOPHARMA, INC. (CBIO), totaling $894.2K in disclosed volume. Weighing $0 bought versus $33.1K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Sep 18 | CBIO CRESCENT BIOPHARMA, INC. | Im Ellie Eunkyung | Chief Medical Officer | Sell | $11.2K |
| Jun 23 | CBIO CRESCENT BIOPHARMA, INC. | Im Ellie Eunkyung | Chief Medical Officer | Sell | $21.9K |
| Dec 17 | CBIO CRESCENT BIOPHARMA, INC. | Im Ellie Eunkyung | Chief Medical Officer | Grant | $861.2K |
3 filings